General Information
Version
006
Revision date
2006-10-18
Product name
rhuMAb-EGFr
Product Synonyms
panitumumab
Chemical name
rhuMAb-EGFr
Manufacturer Name
Amgen Inc
Icons in SDS
Company Information
company name
Amgen Inc
Section 2
SECTION 2: Hazards identification
OSHA Ingredients Single-dose 5cc, 10cc, and 20cc vials containing 100 mg, 200 mg, or 400 mg of active antibody, respectively Formulation 20 mg protein/mL, 100mM sodium chloride, and 50mM sodium acetate pH 5.8 CAS Number 339177-26-3 Synonyms ABX-EGF, others
Health hazards
Caution Pharmaceutical product intended for clinical and manufacturing purposes only. Product contains Vectibix™, a recombinant human IgG2 monoclonal antibody directed against the EGF receptor, an active pharmaceutical ingredient for treatment of cancer. Dosage from contents may pose a health hazard only if significant absorption occurs (e.g., inhalation after major spill or leak). Avoid inhalation, skin contact, eye contact, and accidental ingestion.
Principle Routes of Exposure
Eye Skin Inhalation, skin and eye contact, accidental ingestion. No data with ocular exposure available. No data with dermal exposure available. Based on its molecular weight, Vectibix™ should not be readily absorbed through the skin. Inhalation Ingestion Occupational Exposure Limit No data with inhalation exposure available. No data with oral exposure available.
